227 related articles for article (PubMed ID: 29966535)
41. River Blindness: Mathematical Models for Control and Elimination.
Basáñez MG; Walker M; Turner HC; Coffeng LE; de Vlas SJ; Stolk WA
Adv Parasitol; 2016; 94():247-341. PubMed ID: 27756456
[TBL] [Abstract][Full Text] [Related]
42. Modelling Neglected Tropical Diseases diagnostics: the sensitivity of skin snips for Onchocerca volvulus in near elimination and surveillance settings.
Bottomley C; Isham V; Vivas-Martínez S; Kuesel AC; Attah SK; Opoku NO; Lustigman S; Walker M; Basáñez MG
Parasit Vectors; 2016 Jun; 9(1):343. PubMed ID: 27301567
[TBL] [Abstract][Full Text] [Related]
43. Short report: impact of ivermectin community-level treatments on elimination of adult Onchocerca volvulus when individuals receive multiple treatments per year.
Cupp EW; Cupp MS
Am J Trop Med Hyg; 2005 Dec; 73(6):1159-61. PubMed ID: 16354830
[TBL] [Abstract][Full Text] [Related]
44. The geographic distribution of onchocerciasis in the 20 participating countries of the African Programme for Onchocerciasis Control: (2) pre-control endemicity levels and estimated number infected.
Zouré HG; Noma M; Tekle AH; Amazigo UV; Diggle PJ; Giorgi E; Remme JH
Parasit Vectors; 2014 Jul; 7():326. PubMed ID: 25053392
[TBL] [Abstract][Full Text] [Related]
45. Research for control: the onchocerciasis experience.
Remme JH
Trop Med Int Health; 2004 Feb; 9(2):243-54. PubMed ID: 15040562
[TBL] [Abstract][Full Text] [Related]
46. Elimination of onchocerciasis from Africa: possible?
Mackenzie CD; Homeida MM; Hopkins AD; Lawrence JC
Trends Parasitol; 2012 Jan; 28(1):16-22. PubMed ID: 22079526
[TBL] [Abstract][Full Text] [Related]
47. Onchocerciasis in West Africa after 2002: a challenge to take up.
Hougard JM; Yameogo L; Philippon B
Parasite; 2002 Jun; 9(2):105-11. PubMed ID: 12116855
[TBL] [Abstract][Full Text] [Related]
48. The African Programme for Onchocerciasis Control (APOC).
Amazigo U
Ann Trop Med Parasitol; 2008 Sep; 102 Suppl 1():19-22. PubMed ID: 18718149
[TBL] [Abstract][Full Text] [Related]
49. Progress towards eliminating onchocerciasis in the WHO Region of the Americas: verification of elimination of transmission in Guatemala.
Wkly Epidemiol Rec; 2016 Oct; 91(43):501-5. PubMed ID: 27801556
[No Abstract] [Full Text] [Related]
50. Financial and Economic Costs of the Elimination and Eradication of Onchocerciasis (River Blindness) in Africa.
Kim YE; Sicuri E; Tediosi F
PLoS Negl Trop Dis; 2015; 9(9):e0004056. PubMed ID: 26360917
[TBL] [Abstract][Full Text] [Related]
51. Point prevalence mapping reveals hotspot for onchocerciasis transmission in the Ndikinimeki Health District, Centre Region, Cameroon.
Aza'ah RA; Sumo L; Ntonifor NH; Bopda J; Bamou RH; Nana-Djeunga HC
Parasit Vectors; 2020 Oct; 13(1):519. PubMed ID: 33066826
[TBL] [Abstract][Full Text] [Related]
52. Factors affecting onchocerciasis transmission: lessons for infection control.
Cheke RA
Expert Rev Anti Infect Ther; 2017 Apr; 15(4):377-386. PubMed ID: 28117596
[TBL] [Abstract][Full Text] [Related]
53. How Can Onchocerciasis Elimination in Africa Be Accelerated? Modeling the Impact of Increased Ivermectin Treatment Frequency and Complementary Vector Control.
Verver S; Walker M; Kim YE; Fobi G; Tekle AH; Zouré HGM; Wanji S; Boakye DA; Kuesel AC; de Vlas SJ; Boussinesq M; Basáñez MG; Stolk WA
Clin Infect Dis; 2018 Jun; 66(suppl_4):S267-S274. PubMed ID: 29860291
[TBL] [Abstract][Full Text] [Related]
54. "Cross-border collaboration in onchocerciasis elimination in Uganda: progress, challenges and opportunities from 2008 to 2013".
Lakwo T; Ukety T; Bakajika D; Tukahebwa E; Awaca P; Amazigo U
Global Health; 2018 Feb; 14(1):16. PubMed ID: 29409509
[TBL] [Abstract][Full Text] [Related]
55. Progress toward elimination of onchocerciasis in the Americas.
Sauerbrey M; Rakers LJ; Richards FO
Int Health; 2018 Mar; 10(suppl_1):i71-i78. PubMed ID: 29471334
[TBL] [Abstract][Full Text] [Related]
56. Rapid suppression of Onchocerca volvulus transmission in two communities of the Southern Chiapas focus, Mexico, achieved by quarterly treatments with Mectizan.
Rodríguez-Pérez MA; Lutzow-Steiner MA; Segura-Cabrera A; Lizarazo-Ortega C; Domínguez-Vázquez A; Sauerbrey M; Richards F; Unnasch TR; Hassan HK; Hernández-Hernández R
Am J Trop Med Hyg; 2008 Aug; 79(2):239-44. PubMed ID: 18689630
[TBL] [Abstract][Full Text] [Related]
57. Macrofilaricidal activity after doxycycline only treatment of Onchocerca volvulus in an area of Loa loa co-endemicity: a randomized controlled trial.
Turner JD; Tendongfor N; Esum M; Johnston KL; Langley RS; Ford L; Faragher B; Specht S; Mand S; Hoerauf A; Enyong P; Wanji S; Taylor MJ
PLoS Negl Trop Dis; 2010 Apr; 4(4):e660. PubMed ID: 20405054
[TBL] [Abstract][Full Text] [Related]
58. Modelling Anti-Ov16 IgG4 Antibody Prevalence as an Indicator for Evaluation and Decision Making in Onchocerciasis Elimination Programmes.
Lont YL; Coffeng LE; de Vlas SJ; Golden A; de Los Santos T; Domingo GJ; Stolk WA
PLoS Negl Trop Dis; 2017 Jan; 11(1):e0005314. PubMed ID: 28114304
[TBL] [Abstract][Full Text] [Related]
59. Evaluation of onchocerciasis control in the Upper Denkyira East municipal in the forest area of Ghana: Responses of participants and distributors to the CDTI programme.
Agyemang ANO; Badu K; Baffour-Awuah S; Owusu-Dabo E; Biritwum NK; Garms R; Kruppa TF
Acta Trop; 2018 Sep; 185():357-362. PubMed ID: 29932933
[TBL] [Abstract][Full Text] [Related]
60. Situation analysis of parasitological and entomological indices of onchocerciasis transmission in three drainage basins of the rain forest of South West Cameroon after a decade of ivermectin treatment.
Wanji S; Kengne-Ouafo JA; Esum ME; Chounna PW; Tendongfor N; Adzemye BF; Eyong JE; Jato I; Datchoua-Poutcheu FR; Kah E; Enyong P; Taylor DW
Parasit Vectors; 2015 Apr; 8():202. PubMed ID: 25886166
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
